SCHEMBL22493028

SCHEMBL22493028

O=C(c1ccc([N+](=O)[O-])s1)C1CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.57
RAB9A P51151 1/20 0.56
KMT2A Q03164 4/20 0.48
LMNA P02545 6/20 0.47
HTT P42858 5/20 0.47
MAPT P10636 5/20 0.47
TP53 P04637 1/20 0.47
ALDH1A1 P00352 3/20 0.46
MITF O75030 3/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
ATM Q13315 1/20 0.43
MEN1 O00255 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
POLB P06746 1/20 0.42
TDP2 O95551 1/20 0.42
CASP3 P42574 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23507237 0.93 SMN1; SMN2 (0.58) SMN1; SMN2RAB9AKMT2ALMNAHTT
SCHEMBL2118284 0.78 ATM (0.55) SMN1; SMN2RAB9AKMT2ALMNAHTT
SCHEMBL218867 0.76 SMN1; SMN2 (0.53) SMN1; SMN2RAB9AKMT2ALMNAHTT
SCHEMBL20360513 0.76 SMN1; SMN2 (0.89) SMN1; SMN2RAB9AKMT2ALMNAHTT
SCHEMBL6736049 0.74 SMN1; SMN2 (0.51) SMN1; SMN2RAB9AKMT2ALMNAHTT
Hydrochloric Acid SCHEMBL7036575 0.74 SMN1; SMN2 (0.51) SMN1; SMN2RAB9AKMT2ALMNAHTT
SCHEMBL23529356 0.74 SMN1; SMN2 (0.53) SMN1; SMN2RAB9AKMT2ALMNAHTT
SCHEMBL1937600 0.74 LMNA (0.54) SMN1; SMN2RAB9AKMT2ALMNAHTT
SCHEMBL27938343 0.74 SMN1; SMN2 (0.54) SMN1; SMN2RAB9AKMT2ALMNAHTT
Cyclooctanol SCHEMBL5303490 0.73 RAB9A (0.60) SMN1; SMN2RAB9AKMT2ALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11655203-B2 Nitration ETH ZURICH (CH) 2023-05-23 US disclosed
US-11655203-B2 Nitration ETH ZURICH (CH) 2023-05-23 US disclosed
US-11655203-B2 Nitration ETH ZURICH (CH) 2023-05-23 US disclosed
US-20220009875-A1 NITRATION ETH ZURICH (CH) 2022-01-13 US disclosed
US-20220009875-A1 NITRATION ETH ZURICH (CH) 2022-01-13 US disclosed
EP-3717464-B1 NITRATION ETH ZUERICH (CH) 2021-06-16 EP disclosed
EP-3717464-B1 NITRATION ETH ZUERICH (CH) 2021-06-16 EP disclosed
EP-3717464-A1 NITRATION ETH Zurich (CH) 2020-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220009875-A1 NITRATION NOS1, NOS2, NOS3 SMN1; SMN2 1222/4885RAB9A 3353/4885KMT2A 2374/4885
US-11655203-B2 Nitration NOS1, NOS2, NOS3 SMN1; SMN2 1222/4885RAB9A 3353/4885KMT2A 2374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.